Journal article
Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations
TD Clay, PA Russell, H Do, V Sundararajan, M Conron, GM Wright, A Dobrovic, MM Moore, SA McLachlan
Pathology | ELSEVIER SCIENCE BV | Published : 2016
Grants
Funding Acknowledgements
Dr Clay declares previously receiving financial support to attend scientific meetings from Boehringer Ingelheim and Roche. All other authors state that they have no conflicts of interest to disclose.